Impact of intraprocedural stent thrombosis during Percutaneous coronary intervention: Insights from the champion phoenix trial (clinical trial comparing Cangrelor to Clopidogrel standard of care therapy in subjects who require Percutaneous coronary intervention)

Journal of the American College of Cardiology

Volumn 63, Issue 7, 2014, Pages 619-629

  Généreux, Philippe ^a,b,c   Stone, Gregg W ^a,b   Harrington, Robert A ^d   Gibson, C Michael ^e   Steg, Ph Gabriel ^f,n   Brener, Sorin J ^b,g   Angiolillo, Dominick J ^h   Price, Matthew J ⁱ   Prats, Jayne ^j   Lasalle, Laura ^b   Liu, Tiepu ⁱ   Todd, Meredith ⁱ   Skerjanec, Simona ⁱ   Hamm, Christian W ^k   Mahaffey, Kenneth W ^d   White, Harvey D ^l   Bhatt, Deepak L ^m  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^d STANFORD UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g NEW YORK METHODIST HOSPITAL   (United States)

^h UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

ⁱ SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^j MEDICINES COMPANY   (United States)

^k JUSTUS LIEBIG UNIVERSITY   (Germany)

^l AUCKLAND CITY HOSPITAL   (New Zealand)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁿ ROYAL BROMPTON HOSPITAL   (United Kingdom)

more..

Author keywords

cangrelor; IPST; PCI; stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CANGRELOR; CLOPIDOGREL; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BARE METAL STENT; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; HUMAN; INCIDENCE; INTRAPROCEDURAL STENT THROMBOSIS; ISCHEMIA DRIVEN REVASCULARIZATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STENT THROMBOSIS;

CANGRELOR; IPST; PCI; STENT THROMBOSIS;

ADENOSINE MONOPHOSPHATE; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; STANDARD OF CARE; STENTS; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84896691558     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.10.022     Document Type: Article

References (20)

1. D.L. Bhatt, G.W. Stone, and K.W. Mahaffey et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events N Engl J Med 368 2013 1303 1313
2. D.E. Cutlip, S. Windecker, and R. Mehran et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
3. A. Chieffo, E. Bonizzoni, and D. Orlic et al. Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents Circulation 109 2004 2732 2736
4. G.G. Biondi-Zoccai, G.M. Sangiorgi, and A. Chieffo et al. Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era Am J Cardiol 95 2005 1466 1468
5. S.J. Brener, E. Cristea, and A.J. Kirtane et al. Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes J Am Coll Cardiol Intv 6 2013 36 43
6. S. Leonardi, K.W. Mahaffey, and H.D. White et al. Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial Am Heart J 163 2012 768-76.e2
7. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
8. G.W. Stone, B.T. McLaurin, and D.A. Cox et al. Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
9. G.W. Stone, B. Witzenbichler, and G. Guagliumi et al. Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
10. T. Palmerini, G. Dangas, and R. Mehran et al. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial Circ Cardiovasc Interv 4 2011 577 584
11. G.D. Dangas, B.E. Claessen, and R. Mehran et al. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes J Am Coll Cardiol Intv 5 2012 1097 1105
12. G.W. Stone, B. Witzenbichler, and G. Weisz et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study Lancet 382 2013 614 623
13. A.J. Lansky, K. Goto, and E. Cristea et al. Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial Circ Cardiovasc Interv 3 2010 308 316
14. J. Machecourt, N. Danchin, and J.M. Lablanche et al. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry J Am Coll Cardiol 50 2007 501 508
15. L. Wallentin, R.C. Becker, and A. Budaj et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
16. S.D. Wiviott, E. Braunwald, and C.H. McCabe et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
17. P.G. Steg, R.A. Harrington, and H. Emanuelsson et al. Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial Circulation 128 2013 1055 1065
18. D. Alexopoulos, I. Xanthopoulou, and V. Gkizas et al. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction Circ Cardiovasc Interv 5 2012 797 804
19. T. Grosser, S. Fries, J.A. Lawson, S.C. Kapoor, G.R. Grant, and G.A. FitzGerald Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin Circulation 127 2013 377 385
20. P. den Heijer, D.P. Foley, and J. Escaned et al. Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus J Am Coll Cardiol 24 1994 649 654